检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]贵州省人民医院妇科,贵州贵阳55000 [2]四川大学华西二院妇产科
出 处:《中国妇幼保健》2009年第5期664-667,共4页Maternal and Child Health Care of China
摘 要:目的:探讨脂质体介导的靶向H-ras基因的小发夹状RNA重组质粒对人卵巢癌细胞株SKOV3细胞增殖的抑制作用。方法:实验分4组:正常对照组(仅予脂质体处理)、转染psh RNA/H-ras处理24h组、48h组及72h组。分别于转染后不同时间进行MTT实验、软琼脂克隆形成实验、细胞周期检测和AO/EB双染实验,观察各组细胞增殖、凋亡及细胞周期的变化。结果:FCM显示转染psh RNA/H-ras 24h及48h后的SKOV3细胞均出现细胞周期的抑制,48h后SKOV3细胞有显著的凋亡发生;转染psh RNA/H-ras1和pshRNA/H-ras2对SKOV3细胞克隆形成的抑制率分别为51.5%(P<0.05)和63.3%(P<0.01);MTT检测转染psh RNA/H-ras1和psh RNA/H-ras 272h后对SKOV3细胞增殖抑制率分别为62.5%和64.5%。AO/EB实验显示48h细胞的凋亡率为29.3%(P<0.05)。结论:重组质粒psh RNA/H-ras在人卵巢癌SKOV3细胞中有明显抑制细胞增殖的作用,并介导肿瘤细胞的凋亡。Objective: To explore the cells proliferation effect after transfected pshRNA/H -ras, discuss the rote of H -tas gene in the development of ovarian cancer. Methods: 4 groups were included in the study: control group, 24 hours experimental group, 48 hours experimental group and 72 hours experimental group after transfected pshRNA/H - ras. The influence on proliferation and apoptosis in 4 groups were investigated by MTT assay, cloning test, flow cytometry and AO/EB respectively. Results : The inhibition effect of cell cycle after transfected pshRNA/H - ras 24 hours and 48 hours in SKOV3 strains was detected by FCM. The suppression rates of cloning efficiency were 51.5% (P 〈 0.05 ) and 63.3% (P 〈 0. 01 ) after transfectd pshRNA/H - rasl and pshRNA/H - ras2 in SKOV3, respectively. The apoptosis rate was 29.3% (P 〈0. 05) in AO/EB experiments. The suppression rates of cell proliferation were 62. 5% and 64. 5% after trans- fected pshRNA/H - rasl and pshRNA/H - ras2 72 hours by MTT in SKOV3 respectively. Conclusion : The short hairpin RNA of H - ras can sunnress cells proliferation and enhance the anontosis of tumor cells in SKOV3 efficientlv.
关 键 词:RNA干扰 pshRNA/H—ras 卵巢癌 增殖 凋亡
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222